ONCOLYTICS BIOTECH INC | CIK:0001129928 | 3

  • Filed: 3/19/2018
  • Entity registrant name: ONCOLYTICS BIOTECH INC (CIK: 0001129928)
  • Generator: Workiva (WebFilings)
  • SEC filing page: http://www.sec.gov/Archives/edgar/data/1129928/000112992818000028/0001129928-18-000028-index.htm
  • XBRL Instance: http://www.sec.gov/Archives/edgar/data/1129928/000112992818000028/oncyf-20171231.xml
  • XBRL Cloud Viewer: Click to open XBRL Cloud Viewer
  • EDGAR Dashboard: https://edgardashboard.xbrlcloud.com/edgar-dashboard/?cik=0001129928
  • Open this page in separate window: Click

    • ifrs-full:DisclosureOfCashFlowStatementExplanatory

    Additional Cash Flow Disclosures
     
    Net Change In Non-Cash Working Capital
     
    2017
    $
    2016
    $
    2015
    $
    Change in:
     

     

     

    Contract receivable
    (4,767,100
    )
    —

    —

    Other receivables
    16,680

    285,653

    (148,308
    )
    Prepaid expenses
    (915,222
    )
    245,828

    (215,116
    )
    Accounts payable and accrued liabilities
    (384,641
    )
    1,359,172

    (664,505
    )
    Contract liability
    6,182,580

    —

    —

    Non-cash impact of foreign exchange
    48,558

    343,212

    (77,535
    )
    Change in non-cash working capital related to operating activities
    180,855

    2,233,865

    (1,105,464
    )


    Other Cash Flow Disclosures

    2017
    $
    2016
    $
    2015
    $
    Cash interest received
    130,101

    163,902

    197,859

    Cash taxes paid
    136,163

    4,468

    3,421